Purdue Pharma and the Sackler family reached a landmark settlement of up to $7.4 billion to address their accountability in the opioid crisis. This agreement replaces a previously rejected deal and entails the Sacklers relinquishing ownership of Purdue while contributing $6.5 billion. The settlement aims to compensate victims and fund initiatives to combat the opioid epidemic. This deal also highlights a growing trend of large settlements by opioid manufacturers. Court approval is pending, and further details are expected to be clarified soon.
"We are extremely pleased that a new agreement has been reached that will deliver billions of dollars to compensate victims, abate the opioid crisis, and deliver treatment and overdose rescue medicines that will save lives."
"This new settlement is among the largest achieved in lawsuits holding pharmaceutical companies accountable, totaling up to $7.4 billion to address the ongoing opioid epidemic."
Collection
[
|
...
]